Therapy of dystonia in Japan

Clinical Neurology

Volumn 45, Issue 9, 2005, Pages 634-642

  Mezaki, Takahiro ^a   Hayashi, Akito ^b   Nakase, Hirofumi ^c   Hasegawa, Kazuko ^d  

^a Sakakibara Hakuho Hospital   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Dystonia; Therapy

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; AROTINOLOL; BACLOFEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; BROMOCRIPTINE MESILATE; CARBAMAZEPINE; CHLORPHENESIN CARBAMATE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DANTROLENE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; LEVODOPA; METHYLPHENIDATE; MUSCLE RELAXANT AGENT; PAROXETINE; PERPHENAZINE; PIMOZIDE; PROFENAMINE; PROPRANOLOL; SULPIRIDE; TIAPRIDE; TRIHEXYPHENIDYL; UNINDEXED DRUG; VALPROIC ACID;

ARTICLE; BLEPHAROSPASM; CERVICAL SPINE; DRUG CHOICE; DYSTONIA; EVIDENCE BASED MEDICINE; HUMAN; JAPAN; MUSCLE CRAMP; PRACTICE GUIDELINE; QUESTIONNAIRE; REGRESSION ANALYSIS; SPINE DISEASE; STATISTICAL SIGNIFICANCE; STEREOTAXIC SURGERY; WRITERS CRAMP;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BOTULINUM TOXIN TYPE A; CHOLINERGIC ANTAGONISTS; DYSTONIA; DYSTONIC DISORDERS; HUMANS; HYPNOTICS AND SEDATIVES; NERVE BLOCK; NEUROMUSCULAR AGENTS; QUESTIONNAIRES; TORTICOLLIS;

EID: 27244459448     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Fahn S: Concept and classification of dystonia. Adv Neurol 1988; 50: 1-8
2. Jankovic J: Medical therapy and botulinum toxin in dystonia. Adv Neurol 1998; 78: 169-183
3. Brans JWM, Lindeboom R, Snoek JW, et al: Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology 1996; 46: 1066-1072
4. Ohara S, Hayashi R, Momoi H, et al: Mexiletine in the treatment of spasmodic torticollis. Mov Disord 1998; 13: 934-940
5. Ohara S, Tsuyuzaki J, Hayashi R: Mexiletine in the treatment of blepharospasm: experience with the first three patients. Mov Disord 1999; 14: 173-175
6. Anderson RL: Myectomy provides best functional surgical improvement for blepharospasm. Ocul Surg News Intl 2000; 11: 46-48
7. Fahn S, Williams DT: Psychogenic dystonia. Adv Neurol 1988; 50: 431-455
8. Cooper IS: The Victim is always the same. W.W. Norton & Company. New York. 1976
9. Suzuki T, Tani M, Nabeta R, et al: Evaluations clinique et Electromyographique de l'effet de l'acupuncture sur les patients souffrants de torticolis spasmodique. Méridiens 2000; 115: 17-26
10. Schenk T, Bauer B, Steidle B, et al: Does training improve writer's cramp? An evaluation of a behavioral treatment approach using kinematic analysis. J Hand Ther 2004; 17: 349-363
11. Priori A, Pesenti A, Scarlato G, et al: Limb immobilization for the treatment of focal occupational dystonia. Neurology 2001; 56: 405-409
12. Tsui JKC, Bhatt M, Calne S, et al: Botulinum toxin in the treatment of writer's cramp: a double-blind study. Neurology 1993; 43: 183-185
13. Cole R, Hallen M, Cohen LG: Double-blind trial of botulinum toxin for treatment of focal hand dystonia. Mov Disord 1995; 10: 466-471
14. Taira T, Hori T: Stereotaxic ventrooralis thalamotomy for task-specific focal hand dystonia (writer's cramp). Stereotact Funct Neurosurg 2003; 80: 88-91
15. Clinical use of botulinum toxin. National Institutes of Health Consensus Development Conference statement, November 12-14,1990. Arch Neurol 1991; 48: 1294-1298
16. Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1990; 40: 1332-1336
17. The Canadian Movement Disorders Group: Consensus statement on physician training for the treatment of dystonia with botulinum toxin. Can J Neurobiol Sci 1992; 19: 522
18. Berardelli A, Abbruzzese G, Bertolasi L, et al: Guidelines for the therapeutic use of botulinum toxin in movement disorders. Ital J Neurol Sci 1997; 18: 261-269